Tabernanthalog
CAS No. 2483829-58-7
Tabernanthalog( —— )
Catalog No. M35384 CAS No. 2483829-58-7
Tabernanthalog (TBG) is a 5-HT2A agonist. In rodents,Tabernanthalog has been found to promote structural neuroplasticity, reduce alcohol-seeking and heroin-seeking behavior, and produce antidepressant effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | Get Quote |
|
| 5MG | 426 | Get Quote |
|
| 10MG | 625 | Get Quote |
|
| 25MG | 908 | Get Quote |
|
| 50MG | 1270 | Get Quote |
|
| 100MG | 1701 | Get Quote |
|
| 500MG | 3402 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTabernanthalog
-
NoteResearch use only, not for human use.
-
Brief DescriptionTabernanthalog (TBG) is a 5-HT2A agonist. In rodents,Tabernanthalog has been found to promote structural neuroplasticity, reduce alcohol-seeking and heroin-seeking behavior, and produce antidepressant effects.
-
DescriptionTabernanthalog (TBG) is a 5-HT2A agonist. In rodents,Tabernanthalog has been found to promote structural neuroplasticity, reduce alcohol-seeking and heroin-seeking behavior, and produce antidepressant effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
Target5-HT Receptor
-
Recptor5-HT Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2483829-58-7
-
Formula Weight230.31
-
Molecular FormulaC14H18N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C)C=1C=C2C(C3=C(N2)CCN(C)CC3)=CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SB 243213
SB 243213 is an orally available and selective 5-HT2C receptor antagonist.SB 243213 has anxiolytic and antidepressant activity and is used in schizophrenia and movement disorders.
-
Cilansetron
Cilansetron is an effective and selective 5-HT3 receptor antagonist that can be used for related diseases caused by colitis.
-
Liafensine
Liafensine(BMS-820836) is a novel and selective triple monoamine reuptake inhibitor with inhibitory effects on the reuptake of serotonin, norepinephrine, and dopamine for the study of major depressive disorder and central nervous system disorders.
Cart
sales@molnova.com